2024
Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial
Melink Z, Lustberg M, Schnell P, Mezzanotte-Sharpe J, Orchard T. Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial. Breast Cancer Research And Treatment 2024, 1-13. PMID: 39143391, DOI: 10.1007/s10549-024-07457-w.Peer-Reviewed Original ResearchState-Trait Anxiety InventoryCES-DRandomized controlled trialsBC survivorsCancer survivorsEpidemiologic Studies Depression ScaleEffects of minocyclineBreast cancer survivorsCES-D scoresCognitive functionStage I-III BCSelf-reported cognitionCohort of BC survivorsBreast cancerAffective behaviorBaseline to 6Depression ScaleSub-group analysisInflammatory markersPost-chemotherapyAnxiety InventoryInterleukin-8State-TraitBaseline scoresControlled trials
2023
A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship
Madison A, Filatov M, Andridge R, Haas G, Povoski S, Agnese D, Lustberg M, Reinbolt R, Wesolowski R, Williams N, Malarkey W, Kiecolt-Glaser J. A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship. PLOS ONE 2023, 18: e0283849. PMID: 37000800, PMCID: PMC10065250, DOI: 10.1371/journal.pone.0283849.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsMood disorder historyExercise stress testCancer survivorsCardiovascular diseaseDisorder historyDepressive symptomsTreatment typeEpidemiologic Studies Depression ScaleNon-cancer causesBreast cancer survivorshipStructured Clinical InterviewAdvanced cancer treatmentStress testCardiotoxic treatmentsAdjuvant treatmentCross-sectional relationshipAntidepressant useTrunk fatCVD developmentVisit 1Depression ScaleCancer survivorshipPhysical activityClinical Interview